ConvaTec Group Plc Share Price

Equities

CTEC

GB00BD3VFW73

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 16:35:07 08/05/2024 BST 5-day change 1st Jan Change
261.2 GBX +0.15% Intraday chart for ConvaTec Group Plc +6.18% +6.96%
Sales 2024 * 2.27B 182B Sales 2025 * 2.41B 193B Capitalization 6.68B 535B
Net income 2024 * 195M 15.62B Net income 2025 * 249M 19.95B EV / Sales 2024 * 3.42 x
Net Debt 2024 * 1.08B 86.53B Net Debt 2025 * 890M 71.3B EV / Sales 2025 * 3.14 x
P/E ratio 2024 *
34 x
P/E ratio 2025 *
26.4 x
Employees 10,136
Yield 2024 *
1.98%
Yield 2025 *
2.15%
Free-Float 79.88%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.15%
1 week+6.18%
Current month+4.48%
1 month-9.12%
3 months+11.34%
6 months+23.09%
Current year+6.96%
More quotes
1 week
251.60
Extreme 251.6
266.40
1 month
244.40
Extreme 244.4
292.00
Current year
232.40
Extreme 232.4
295.20
1 year
195.10
Extreme 195.1
295.20
3 years
165.30
Extreme 165.3
295.20
5 years
136.00
Extreme 136
295.20
10 years
113.25
Extreme 113.25
349.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 29/09/19
Director of Finance/CFO 60 30/01/22
Chief Operating Officer - 31/03/22
Members of the board TitleAgeSince
Director/Board Member 58 31/01/22
Chairman 76 29/09/19
Director/Board Member 69 13/08/17
More insiders
Date Price Change Volume
08/05/24 261.2 +0.15% 5,714,109
07/05/24 260.8 +0.77% 3,596,311
03/05/24 258.8 +3.77% 5,611,696
02/05/24 249.4 +1.38% 8,721,258
01/05/24 246 -1.60% 2,474,950

Delayed Quote London S.E., May 08, 2024 at 04:35 pm

More quotes
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, incontinence and critical care. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (29.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - incontinence and critical care (26.4%); - ostomy care (25.2%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - infusion (18.5%). At the end of 2022, the group operated 9 production sites worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (33.2%), Americas (52.6%) and Asia/Pacific (14.2%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
3.263 USD
Average target price
3.957 USD
Spread / Average Target
+21.27%
Consensus